Michael E. Johnson

According to our database, Michael E. Johnson authored at least 5 papers between 2012 and 2023.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2023

Evaluation of interactions between the hepatitis C virus NS3/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations.

Jinhong Ren, Tasneem M. Vaid, Hyun Lee, Isabel Ojeda, Michael E. Johnson

J. Comput. Aided Mol. Des., January, 2023

2016

Evaluating thermodynamic integration performance of the new amber molecular dynamics package and assess potential halogen bonds of enoyl-ACP reductase (FabI) benzimidazole inhibitors.

Pin-Chih Su, Michael E. Johnson

J. Comput. Chem., 2016

2015

Comparison of radii sets, entropy, QM methods, and sampling on MM-PBSA, MM-GBSA, and QM/MM-GBSA ligand binding energies of <i>F</i><i>. tularensis</i> enoyl-ACP reductase (FabI).

Pin-Chih Su, Cheng-Chieh Tsai, Shahila Mehboob, Kirk E. Hevener, Michael E. Johnson

J. Comput. Chem., 2015

2013

Fragment-Based Drug Discovery Using a Multidomain, Parallel MD-MM/PBSA Screening Protocol.

Tian Zhu, Hyun Lee, Hao Lei, Christopher Jones, Kavankumar Patel, Michael E. Johnson, Kirk E. Hevener

J. Chem. Inf. Model., 2013

2012

Identification of Non-Macrocyclic Small Molecule Inhibitors against the NS3/4A Serine Protease of Hepatitis C Virus through in Silico Screening.

Rima Chaudhuri, Hyun Lee, Lena Truong, Jaime Torres, Kavankumar Patel, Michael E. Johnson

J. Chem. Inf. Model., 2012